These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27329210)

  • 21. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A.
    Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J
    Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab in the treatment of acquired factor VIII inhibitors.
    Onitilo AA; Skorupa A; Lal A; Ronish E; Mercier RJ; Islam R; Lazarchick J
    Thromb Haemost; 2006 Jul; 96(1):84-7. PubMed ID: 16807656
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term response to rituximab in a patient with acquired hemophilia].
    García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
    Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis.
    Franchini M; Mengoli C; Lippi G; Targher G; Montagnana M; Salvagno GL; Zaffanello M; Cruciani M
    Haemophilia; 2008 Sep; 14(5):903-12. PubMed ID: 18671801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current management of acquired factor VIII inhibitors.
    Barnett B; Kruse-Jarres R; Leissinger CA
    Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment.
    Hauser I; Schneider B; Lechner K
    Thromb Haemost; 1995 Jan; 73(1):1-5. PubMed ID: 7740477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland.
    Tiede A; Huth-Kühne A; Oldenburg J; Grossmann R; Geisen U; Krause M; Brand B; Alberio L; Klamroth R; Spannagl M; Knöbl P
    Ann Hematol; 2009 Apr; 88(4):365-70. PubMed ID: 19083235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired Haemophilia A. Which is the best therapeutic choice in older adults? Single center study of 4 cases.
    Mauro E; Garlatti Costa E; Zanier A; Maset M; Ermacora A; Ghersetti M; Casarin P
    Reumatismo; 2019 Apr; 71(1):37-41. PubMed ID: 30932442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bullous pemphigoid and acquired haemophilia].
    Kluger N; Navarro R; Pallure V; Guillot B
    Ann Dermatol Venereol; 2011 May; 138(5):422-3. PubMed ID: 21570569
    [No Abstract]   [Full Text] [Related]  

  • 30. Mycophenolate in the remission induction of a patient with acquired haemophilia A.
    Lee YS; Ng HJ
    Haemophilia; 2010 Jan; 16(1):180-2. PubMed ID: 19780847
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
    Hertzberg MS; Favaloro E; Koutts J
    Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
    [No Abstract]   [Full Text] [Related]  

  • 32. Acquired hemophilia A: clinical features, surgery and treatment of 34 cases, and experience of using recombinant factor VIIa.
    Lak M; Sharifian RA; Karimi K; Mansouritorghabeh H
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):294-300. PubMed ID: 19211581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid.
    Cho YT; Chu CY; Wang LF
    Br J Dermatol; 2015 Jul; 173(1):302-4. PubMed ID: 25529394
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibitor development and management in three non-severe haemophilia A patients with T295A variant.
    Ivaskevicius V; Goldmann G; Horneff S; Marquardt N; Klein C; Albert T; Zeitler H; Oldenburg J
    Hamostaseologie; 2014; 34 Suppl 1():S9-12. PubMed ID: 25382774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of 65 patients with acquired hemophilia A in Taiwan.
    Huang SY; Tsay W; Lin SY; Hsu SC; Hung MH; Shen MC
    J Formos Med Assoc; 2015 Apr; 114(4):321-7. PubMed ID: 25839765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficiency of rituximab in acquired hemophilia: report of two cases and review of literature].
    Millet A; Decaux O; Bareau B; Guillet B; Cazalets C; Perlat A; Jego P; Grosbois B
    Rev Med Interne; 2007 Dec; 28(12):862-5. PubMed ID: 17707554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acquired haemophilia: From registers' data to therapeutic recommendations].
    Lévesque H
    Rev Med Interne; 2013 Jan; 34(1):1-3. PubMed ID: 22998977
    [No Abstract]   [Full Text] [Related]  

  • 38. Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: a 10-year follow-up study.
    Pardos-Gea J; Altisent C; Parra R; Vilardell-Tarrès M; Ordi-Ros J
    Haemophilia; 2012 Sep; 18(5):789-93. PubMed ID: 22429259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acquired hemophilia A. A monocentric retrospective study of 39 patients].
    Graveleau J; Trossaërt M; Leux C; Masseau A; Ternisien C; Néel A; Fouassier M; Agard C; Sigaud M; Hamidou M
    Rev Med Interne; 2013 Jan; 34(1):4-11. PubMed ID: 23246283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor VIII antibodies: immunosuppressive therapy.
    Green D
    Ann N Y Acad Sci; 1975 Jan; 240():389-99. PubMed ID: 1078622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.